The October 2018 digital edition includes MM&M’s annual Career and Salary Survey, pipeline watch, and the pro ad report for the first half of 2018.
Lynn O’Connor Vos is president and CEO of Muscular Dystrophy Association.
With the increasing use of tech to engage patients, what new approaches hold the most promise to remedy non-adherence?
Big pharma should extend its vision beyond the blockbusters to make room for orphan drugs.
FCB Health chief creative officer Rich Levy analyzes six campaigns the jury debated long and hard at this year’s Cannes Lions International Festival of Creativity.
With less than 14% of Phase I to III drug candidates winning FDA approval, unforeseen roadblocks can derail even the most promising clinical research programs.
Akebia Therapeutics president and CEO John Butler muses on the opportunity to bring his company to the forefront of the renal space.
Michael Parisi, CEO, Guidemark Health, talks small agency dynamics.
Healthcare-first agencies face a challenge to find A-grade talent among the plethora of job applicants. MM&M asked HR experts at firms of all sizes what the perfect candidate looks like.
There’s no such thing as a “typical” career path in pharma and healthcare. Ten executives share their journeys and the lessons they learned along the way.
Get to know each of these companies by learning about their culture, work/life balance, D&I initiatives and more.
OptimizeRx’s Chris DiCostanzo and Rebecca Love explain the value of reaching patients and HCPs when it matters most.
Talking Medicines’ Jo Halliday discussed how the pharmaceutical sector can better understand the voice of the patient.
Learn about Intouch Group’s journey to foster I+D so that its inclusive culture translates into inclusive healthcare marketing.
Any EHR provider delivering a quality solution should be able to answer these six questions.
Please login or register first to view this content.